US Broker Ratings

Veracyte, Inc. (VCYT) Stock Analysis: Impressive Revenue Growth Amidst Strong Buy Ratings

Veracyte, Inc. (VCYT) stands out as an intriguing player in the healthcare sector, particularly within the diagnostics and research industry. Based in South San Francisco, California,..

Alvotech (ALVO) Stock Analysis: Exploring a Potential 328% Upside in the Biosimilar Market

Alvotech (ALVO), a Luxembourg-based biotech firm specializing in biosimilar medicines, is capturing investor attention with its remarkable potential upside of 328.15%. As a player in the..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: An Investor’s Guide to 22.97% Potential Upside

PTC Therapeutics, Inc. (NASDAQ: PTCT), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its focus on rare disorders and a..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 62.3% Upside Potential in Biotech Innovation

Investors looking at the healthcare sector, particularly in the biotechnology industry, may find Zai Lab Limited (NASDAQ: ZLAB) a compelling opportunity. With a current market capitalization..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A Promising 22% Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a biopharmaceutical company focused on neuroscience, is currently capturing the attention of investors with its potential for substantial upside. Based in..

Warby Parker Inc. (WRBY) Investor Outlook: Analyzing a 22.63% Potential Upside in the Healthcare Sector

Warby Parker Inc. (NYSE: WRBY), a trailblazer in the eyewear industry with a strong presence in both retail and e-commerce across the United States and Canada,..

PROCEPT BioRobotics Corporation (PRCT): Investor Outlook on a Potential 52% Upside in the Healthcare Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a prominent player in the healthcare sector, particularly within the medical devices industry, is drawing investor attention with its innovative surgical..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 30% Potential Upside Amid Robust Growth

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is attracting significant investor attention as it navigates the competitive biotechnology landscape, focusing on neurological and rare disease treatments. This article..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 10.83% Potential Upside Amidst Healthcare Innovation

ICU Medical, Inc. (ICUI), a prominent player in the Healthcare sector specializing in Medical Instruments & Supplies, offers promising opportunities for investors seeking growth in the..

Haemonetics Corporation (HAE) Stock Analysis: Unpacking a 10.78% Potential Upside for Investors

For investors seeking exposure in the healthcare sector, Haemonetics Corporation (NYSE: HAE) presents a compelling opportunity. With a market capitalization of $3.55 billion, this Boston-based medical..

Perrigo Company plc (PRGO): Exploring a 55% Upside Potential Amidst High Dividend Yields

Perrigo Company plc (NYSE: PRGO), a stalwart in the healthcare sector, stands as a prominent player in the drug manufacturers industry, focusing on specialty and generic..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a $10 Billion Valuation and Strategic Growth in Genetic Medicine

Krystal Biotech, Inc. (NASDAQ: KRYS), a burgeoning player in the biotechnology sector, is capturing investor interest with its strategic focus on genetic medicines targeting diseases with..

Guardant Health, Inc. (GH) Stock Analysis: Unpacking a 48% Revenue Growth in the Diagnostics Sector

Guardant Health, Inc. (NASDAQ: GH) has emerged as a formidable player in the diagnostics and research segment of the healthcare industry. With a market capitalization of..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 33.81% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare sector, has been a topic of interest among investors due to its extensive range..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth with a 15.59% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specifically within the drug manufacturing industry for specialty and generic products, presents an..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a Potential 11.54% Upside

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare industry, primarily focuses on medical instruments and supplies, particularly within the eye health sector. With..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 23.48% ROE in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector known for its diagnostic and therapeutic innovations, presents an intriguing prospect for investors keen..

TG Therapeutics, Inc. (TGTX): Investor Outlook on a Biotech Powerhouse with 6.39% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a significant player in the biotechnology sector, boasting a market capitalization of $8.4 billion. Renowned for its innovative approach..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 22.65% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, has been capturing investor attention with its promising pipeline and robust market performance. With..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Growth Potential Amidst a 12.36% Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, operates as a leading pharmaceutical entity within the specialty and generic drug manufacturing..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds